Table 3

Frequency of treatment use in hospitalised patients with different haematological malignancies

Total study populationAcute leukaemiaChronic lymphoid leukaemiaChronic myeloid leukaemiaHodgkin’s lymphomaMultiple myelomaMyelodysplastic syndromesNon-Hodgkin’s lymphoma
n=46 629n=11 531n=4161n=1157n=1022n=8803n=6693n=13 262
n (%)n (%)*n (%)*n (%)*n (%)*n (%)*n (%)*n (%)*
Last month before death
 Chemotherapy11 419 (24.5)3007 (26.1)699 (16.8)100 (8.6)293 (28.7)2495 (28.3)619 (9.3)3986 (30.1)
 Blood transfusion22 623 (48.5)7793 (67.6)1631 (39.2)555 (48.0)356 (34.9)3813 (43.3)4044 (60.4)4423 (33.4)
 Invasive ventilation5718 (12.3)1180 (10.2)689 (16.6)216 (18.7)194 (19.0)911 (10.3)1040 (15.5)1575 (11.9)
 Haemodynamic support6577 (14.1)1339 (11.6)746 (17.9)250 (21.6)217 (21.3)1096 (12.4)1187 (17.7)1820 (13.7)
 Radiation therapy864 (1.9)63 (0.5)21 (0.5)4 (0.4)13 (1.3)368 (4.2)29 (0.4)344 (2.6)
 Artificial nutrition4539 (9.7)874 (7.6)468 (11.2)138 (11.9)149 (14.6)754 (8.6)734 (11.0)1463 (11.0)
 Tracheotomy3255 (7.0)688 (6.0)391 (9.4)110 (9.5)121 (11.8)525 (6.0)608 (9.1)867 (6.5)
 Cardiopulmonary resuscitation872 (1.9)171 (1.5)106 (2.5)39 (3.4)35 (3.5)134 (1.5)161 (2.4)238 (1.8)
 Dialysis3498 (7.5)557 (4.8)320 (7.7)110 (9.5)89 (8.7)1108 (12.6)522 (7.8)824 (6.2)
Last 2 weeks before death
 Chemotherapy8113 (17.4)2274 (19.7)452 (10.9)63 (5.4)183 (17.9)1642 (18.7)402 (6.0)2816 (21.2)
 Blood transfusion19 441 (41.7)6798 (59.0)1424 (34.2)474 (41.0)303 (29.6)3195 (36.3)3495 (52.2)3749 (28.3)
 Invasive ventilation5654 (12.1)1175 (10.2)684 (16.4)216 (18.6)193 (18.9)898 (10.2)1033 (15.4)1547 (11.7)
 Haemodynamic support6393 (13.7)1302 (11.3)731 (17.6)247 (21.3)213 (20.8)1058 (12)1151 (17.2)1761 (13.3)
 Radiation therapy620 (1.3)47 (0.4)16 (0.4)4 (0.3)10 (1.0)265 (3.0)24 (0.4)242 (1.8)
 Artificial nutrition4227 (9.1)820 (7.1)448 (10.8)131 (11.3)139 (13.6)709 (8.1)710 (10.6)1323 (10.0)
 Tracheotomy3206 (6.9)685 (5.9)384 (9.2)109 (9.4)118 (11.5)517 (5.9)591 (8.8)848 (6.4)
 Cardiopulmonary resuscitation869 (1.9)171 (1.5)106 (2.5)39 (3.4)35 (3.5)134 (1.5)156 (2.3)237 (1.8)
 Dialysis3419 (7.3)550 (4.8)317 (7.6)109 (9.5)88 (8.7)1073 (12.2)515 (7.7)800 (6.0)
  • *Sex-standardised and age-standardised values, using the total study population as reference. Due to this weighting, the sum of exposed individuals in each group may exceed the total (non-standardised) number of exposed individuals in the study population.